{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Concentration of malaria deaths in sub-Saharan Africa\",\"Impact\":\"High number of deaths, especially in vulnerable populations\",\"Mitigation\":\"Increased investment in malaria intervention programs\",\"Technologies\":\"Malaria prevention and treatment technologies\",\"People\":\"Populations in sub-Saharan Africa\",\"Owner\":\"International agencies, governments, and NGOs\"},{\"Description\":\"Lack of long-term financial sustainability for malaria intervention programs\",\"Impact\":\"Reduction in funding and program effectiveness\",\"Mitigation\":\"Developing sustainable funding models, seeking private sector partnerships\",\"Technologies\":\"Financial planning and management tools\",\"People\":\"USAID, WHO, Wellcome Trust, Roll Back Malaria Group, Presidential Malaria Initiative, Global Fund\",\"Owner\":\"International agencies, governments, and NGOs\"},{\"Description\":\"Opposing trend of decreasing malaria cases and increasing costs for prevention\",\"Impact\":\"Financial burden, potential decrease in intervention effectiveness\",\"Mitigation\":\"Improved cost-effective prevention strategies, quality assurance for interventions\",\"Technologies\":\"Cost-effective malaria prevention technologies, intervention monitoring tools\",\"People\":\"Populations at risk of malaria, public health organizations\",\"Owner\":\"International agencies, public health organizations\"},{\"Description\":\"Quality-related concerns over drug efficacy, safety, and surveillance\",\"Impact\":\"Potential decrease in intervention effectiveness, drug resistance\",\"Mitigation\":\"Enhanced surveillance, drug development, and safety regulations\",\"Technologies\":\"Drug quality testing tools, surveillance technologies, drug development technologies\",\"People\":\"Healthcare professionals, populations at risk of malaria\",\"Owner\":\"Health organizations, regulatory agencies\"},{\"Description\":\"Inadequate approach to managing the risk of vector-borne diseases like malaria\",\"Impact\":\"Lack of transformative impact on disease elimination\",\"Mitigation\":\"Development of innovative strategies, alignment with UN SDGs and global agendas\",\"Technologies\":\"Innovative disease prevention technologies, urban planning tools\",\"People\":\"Populations at risk of vector-borne diseases\",\"Owner\":\"International agencies, governments, and NGOs\"}]}"}}